On January 2, 2019 Forbius, a clinical-stage company developing biologics for the treatment of fibrosis and cancer, reported that Ilia Tikhomirov, CEO of Forbius, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference (Press release, Forbius, JAN 2, 2019, View Source [SID1234532365]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Tikhomirov’s presentation will take place Wednesday, January 9th at 11:30 am PST in Elizabethan D at the Westin St. Francis Hotel in San Francisco.

On January 2, 2018 BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, reported that management will provide a corporate update at the 2019 Biotech Showcase in San Francisco, California (Press release, BioLineRx, JAN 2, 2019, View Source;p=irol-newsArticle&ID=2381844 [SID1234532344]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2019 Biotech Showcase Presentation Details:

Date: Monday, January 7, 2019

Time: 4:00 p.m. Pacific Time

Webcast: Link to webcast information

The Company will also host institutional investor and partnering meetings at the 8th Annual LifeSci Advisors Corporate Access Event taking place in San Francisco, January 7-9, 2019.

To schedule a meeting with BioLineRx, investors can register on the online system managed by the Company’s US investor relations firm, LifeSci Advisors, LLC, or make a request via e-mail at [email protected].

On January 2, 2019 Clovis Oncology, Inc. (Nasdaq: CLVS) reported that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 4:30 p.m. Pacific time (Press release, Clovis Oncology, JAN 2, 2019, View Source [SID1234532366]). The conference will be held at the Westin St. Francis Hotel in San Francisco.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation and Q&A session can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

On January 2, 2019 LabCorp (NYSE: LH) reported it will participate at the 37th Annual J.P. Morgan Healthcare Conference (Press release, LabCorp, JAN 2, 2019, View Source;p=RssLanding&cat=news&id=2381927 [SID1234532436]). LabCorp’s presentation is scheduled for Tuesday, January 8, 2019 at 1:30 p.m. (PT), followed by a question and answer session at 2:00 p.m. (PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation and the subsequent question and answer session will be available via the Company website at www.labcorp.com and archived for replay.

On January 2, 2019 Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) reported that it will present at the 37th Annual J.P. Morgan Healthcare Conference at 4:00 PM PT (7:00 PM ET) on Tuesday, January 8, 2018. Live audio of the presentation can be accessed by visiting the "Events" page of the company’s website at investor.pacira.com (Press release, Pacira Pharmaceuticals, JAN 2, 2019, View Source;p=irol-newsArticle&ID=2381850 [SID1234532345]). A replay of the webcast will also be available for two weeks following the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!